Travere Therapeutics
TVTX
$5.46
Share price
3.80%
Change (1 day)
-75.85%
Change (1 year)
Categories
EPS for Travere Therapeutics (TVTX)
EPS in 2023 (TTM): -$4.52
According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.52. In 2022 the company made an earnings per share (EPS) of -$4.37 a decrease over its 2021 EPS that were of -$3.03.
EPS history for Travere Therapeutics from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.52 | 3.43% |
| 2022 | -$4.37 | 44.22% |
| 2021 | -$3.03 | -10.09% |
| 2020 | -$3.37 | -2.6% |
| 2019 | -$3.46 | 36.22% |
| 2018 | -$2.54 | 64.94% |
| 2017 | -$1.54 | 20.31% |
| 2016 | -$1.28 | -135.46% |
| 2015 | $3.61 | -175.68% |
| 2014 | -$4.77 | 98.75% |
| 2013 | -$2.40 | 1746.15% |
| 2012 | -$0.13 | 1.34% |
| 2011 | -$0.13 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -94.03% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -77.88% | 🇺🇸 USA |